SREBF1 and type 2 diabetes mellitus: Recent epigenome-wide association studies (EWASs) in blood have identified differentially methylated CpG sites (DMS), in individuals with vs without type 2 diabetes, in genes such as TXNIP, ABCG1 and SREBF1 [8–10].